NLR, ANC, and ALC during the first week after steroid initiation
Days from steroid initiation | N | Median | Mean | Range | SD | P value* |
NLR (ANC/ALC) | ||||||
Pre | 35 | 4.8 | 10.83 | 0.9–61.2 | 15.50 | |
1 | 19 | 10.8 | 13.1 | 1.1–47.2 | 11.40 | 0.0306 |
2 | 17 | 6 | 9.84 | 0.9–23.4 | 7.92 | 0.1522 |
3 | 15 | 8.3 | 14.02 | 0.5–61.9 | 15.98 | 0.1779 |
4 | 13 | 7.9 | 13.25 | 1.9–60.3 | 16.93 | 0.2656 |
5 | 10 | 7.1 | 42.41 | 2.5–190.2 | 74.29 | 0.0977 |
6 | 9 | 9.1 | 13.91 | 2.4–36.3 | 12.66 | 0.8203 |
7 | 9 | 8.2 | 19.19 | 4.9–94.6 | 28.71 | 0.0273 |
ANC (K/µL) | ||||||
Pre | 35 | 5.05 | 6.50 | 2.03–22.31 | 4.40 | |
1 | 19 | 5.17 | 7.20 | 2.41–21.25 | 5.40 | 0.0874 |
2 | 17 | 6.23 | 7.13 | 1.71–16.86 | 3.67 | 0.1594 |
3 | 15 | 6.4 | 7.91 | 1.57–25.98 | 5.98 | 0.0833 |
4 | 13 | 7.31 | 8.01 | 3.67–27.72 | 6.25 | 0.0171 |
5 | 10 | 8.56 | 8.14 | 2.86–14.06 | 3.53 | 0.0020 |
6 | 9 | 7.76 | 9.97 | 3.34–26.39 | 7.18 | 0.0039 |
7 | 9 | 10.92 | 13.47 | 3.91–29.34 | 8.21 | 0.0039 |
ALC (K/µL) | ||||||
Pre | 35 | 1.03 | 1.18 | 0.15–2.57 | 0.68 | |
1 | 19 | 0.54 | 0.84 | 0.22–2.29 | 0.67 | 0.0243 |
2 | 17 | 0.79 | 1.15 | 0.3–2.45 | 0.69 | 0.9265 |
3 | 15 | 0.77 | 0.99 | 0.35–2.86 | 0.70 | 1.0000 |
4 | 13 | 0.78 | 1.10 | 0.27–2.56 | 0.70 | 0.5417 |
5 | 10 | 0.83 | 1.01 | 0.06–3.12 | 0.89 | 0.3750 |
6 | 9 | 0.83 | 1.07 | 0.4–2.85 | 0.77 | 0.5703 |
7 | 9 | 0.95 | 1.26 | 0.31–3.63 | 1.00 | 0.8203 |
Thirty-five patients had labs drawn within the first week after steroid initiation. Available matched NLR, ANC, and ALC pre and post values were compared at each day after starting steroids through day 7. Numbers in bold indicate a p value <0.05
*Wilcoxon signed-rank test for paired pre and post values available at each timepoint.
ALC, absolute lymphocyte count; ANC, absolute neutrophil count; NLR, neutrophil-to-lymphocyte ratio.